Fluticasone/formoterol - Eurofarma
Alternative Names: Fluticasone propionate/formoterol fumarate dihydrate; Formoterol fumarate dihydrate/fluticasone propionate; Formoterol/fluticasone; Lugano®Latest Information Update: 05 May 2023
At a glance
- Originator Eurofarma
- Class Antiallergics; Antiasthmatics; Ethanolamines; Glucocorticoids; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Asthma
Most Recent Events
- 19 Apr 2023 Preclinical trials in Asthma in Brazil (Inhalation) before April 2023
- 19 Apr 2023 Eurofarma plans a phase III FORASMA trial for Asthma (In children, In adults, In the elderly) in Brazil (Inhalation) in July 2024 (NCT05735431)